West Pharmaceutical Services, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $182.9M | $71.0M | $111.9M | $18.6M |
| FY2015 | $212.4M | $80.8M | $131.6M | $29.6M |
| FY2016 | $219.4M | $49.2M | $170.2M | $19.5M |
| FY2017 | $263.3M | $132.5M | $130.8M | $16.1M |
| FY2018 | $288.6M | $183.9M | $104.7M | $15.1M |
| FY2019 | $367.2M | $240.8M | $126.4M | $24.4M |
| FY2020 | $472.5M | $298.1M | $174.4M | $34.0M |
| FY2021 | $584.0M | $330.6M | $253.4M | $37.5M |
| FY2022 | $724.0M | $439.4M | $284.6M | $23.7M |
| FY2023 | $776.5M | $414.5M | $362.0M | $23.3M |